Soichiro Morinaga

4.0k total citations · 1 hit paper
162 papers, 2.4k citations indexed

About

Soichiro Morinaga is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Soichiro Morinaga has authored 162 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Oncology, 68 papers in Surgery and 65 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Soichiro Morinaga's work include Pancreatic and Hepatic Oncology Research (70 papers), Gastric Cancer Management and Outcomes (29 papers) and Cancer Genomics and Diagnostics (20 papers). Soichiro Morinaga is often cited by papers focused on Pancreatic and Hepatic Oncology Research (70 papers), Gastric Cancer Management and Outcomes (29 papers) and Cancer Genomics and Diagnostics (20 papers). Soichiro Morinaga collaborates with scholars based in Japan, United States and South Korea. Soichiro Morinaga's co-authors include Yasushi Rino, Manabu Shiozawa, Makoto Akaike, Munetaka Masuda, Naoto Yamamoto, Katsuhiko Uesaka, Yasuhiro Shimizu, Satoshi Hirano, Masaru Konishi and Akira Fukutomi and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Soichiro Morinaga

150 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

2016 742 citations Katsuhiko Uesaka, Narikazu Boku et al. The Lancet profile →

Peers

Soichiro Morinaga

ONCOL

SURGE

PRM

EPIDE

Yuichi Nagakawa Japan

Koji Murono Japan

Masato Nagino Japan

J. Pablo Arnoletti United States

M. Klimpfinger Austria

Markus Wagner Switzerland

Hisashi Nagahara Japan

Hiroyuki Takamura Japan

Yukiharu Hiyoshi Japan

Hisashi Ikoma Japan

Yuichi Nagakawa Japan

Soichiro Morinaga

1.5k ×0.9

ONCOL

1.2k ×1.4

SURGE

1.0k ×1.3

PRM

363 ×0.7

263 ×0.6

EPIDE

Citations per year, relative to Soichiro Morinaga Soichiro Morinaga (= 1×) peers Yuichi Nagakawa

Countries citing papers authored by Soichiro Morinaga

Since Specialization

Citations

This map shows the geographic impact of Soichiro Morinaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soichiro Morinaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soichiro Morinaga more than expected).

Fields of papers citing papers by Soichiro Morinaga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soichiro Morinaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soichiro Morinaga. The network helps show where Soichiro Morinaga may publish in the future.

Co-authorship network of co-authors of Soichiro Morinaga

This figure shows the co-authorship network connecting the top 25 collaborators of Soichiro Morinaga. A scholar is included among the top collaborators of Soichiro Morinaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soichiro Morinaga. Soichiro Morinaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takahashi, Kenta, Yasuharu Ueno, Masayuki Ohtsuka, et al.. (2025). Protocol for generating a pancreatic cancer organoid associated with heterogeneous tumor microenvironment. STAR Protocols. 6(1). 103539–103539. 3 indexed citations

Nakachi, Kohei, Masafumi Ikeda, Masaru Konishi, et al.. (2024). Adjuvant S-1 vs. observation for resected biliary tract cancer: 5-year follow-up of the JCOG1202/ASCOT.. Journal of Clinical Oncology. 42(16_suppl). 4119–4119. 1 indexed citations

Wei, Feifei, Taku Kouro, Yuko Nakamura, et al.. (2024). Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation. Computational and Structural Biotechnology Journal. 23. 859–869. 6 indexed citations

Yanagisawa, K, Yasuharu Ueno, Takanori Konishi, et al.. (2024). A pancreatic cancer organoid incorporating macrophages reveals the correlation between the diversity of tumor-associated macrophages and cancer cell survival. Biomaterials. 314. 122838–122838. 8 indexed citations

Takahashi, Daishi, ITARU HASHIMOTO, Satoshi Kobayashi, et al.. (2024). Prognostic nutritional index is an independent risk factor for continuing S-1 adjuvant chemotherapy in patients with pancreatic cancer who received neoadjuvant chemotherapy and surgical resection. BMC Cancer. 24(1). 1469–1469. 3 indexed citations

Takahashi, Kenta, Yasuharu Ueno, Yoichi Furukawa, et al.. (2023). Incorporation of human iPSC-derived stromal cells creates a pancreatic cancer organoid with heterogeneous cancer-associated fibroblasts. Cell Reports. 42(11). 113420–113420. 16 indexed citations

Kobayashi, Shogo, Masafumi Ikeda, Masaru Konishi, et al.. (2023). Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202. European Journal of Surgical Oncology. 50(2). 107324–107324. 3 indexed citations

Sato, Shinya, Masatoshi Nakagawa, Takeshi Terashima, et al.. (2023). EphA2 Proteolytic Fragment as a Sensitive Diagnostic Biomarker for Very Early-stage Pancreatic Ductal Carcinoma. Cancer Research Communications. 3(9). 1862–1874. 3 indexed citations

Murakawa, Masaaki, Naoto Yamamoto, Satoshi Kobayashi, et al.. (2023). Clinical therapeutic effects of neoadjuvant chemotherapy in resectable pancreatic cancer.. Journal of Clinical Oncology. 41(4_suppl). 677–677. 1 indexed citations

10.

Fujikawa, Hirohito, KEISUKE KOMORI, Kazuki Kano, et al.. (2021). Prognostic Factors for Gastric Cancer Patients With One Stage IV Factor who Underwent Conversion Surgery. Anticancer Research. 41(2). 1005–1012. 3 indexed citations

11.

Yamamoto, Naoto, Masaaki Murakawa, Toru Aoyama, et al.. (2020). Rapidly progressed neuroendocrine carcinoma in the extrahepatic bile duct: a case report and review of the literature. SHILAP Revista de lepidopterología. 6(1). 191–191. 6 indexed citations

12.

Hara, Kentaro, Tsutomu Hayashi, Shinsuke Nagasawa, et al.. (2019). An easy and reliable method to close Petersen's defect using barbed suture to prevent internal hernia from developing after gastrectomy with Roux‐en‐Y reconstruction. Asian Journal of Endoscopic Surgery. 13(2). 238–241. 3 indexed citations

13.

Hiroshima, Yukihiko, Rika Kasajima, Yayoi Kimura, et al.. (2019). Novel targets identified by integrated cancer-stromal interactome analysis of pancreatic adenocarcinoma. Cancer Letters. 469. 217–227. 18 indexed citations

14.

Numata, Koji, Yusuke Katayama, Sho Sawazaki, et al.. (2019). Utility of Preoperative Imaging for Predicting Pelvic Lateral Lymph Node Metastasis in Lower Rectal Cancer. Indian Journal of Surgical Oncology. 10(4). 582–586. 1 indexed citations

15.

Uesaka, Katsuhiko, Narikazu Boku, Akira Fukutomi, et al.. (2016). Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). The Lancet. 388(10041). 248–257. 742 indexed citations breakdown →

16.

Katayama, Yusuke, Soichiro Morinaga, Masakatsu Numata, et al.. (2013). A Case of Resection for Complete Spontaneous Necrosis of Hepatocellular Carcinoma. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 74(10). 2863–2868. 3 indexed citations

17.

Tamagawa, Hiroshi, Takashi Oshima, Kazue Yoshihara, et al.. (2012). The Expression of the Phosphatase Regenerating Liver 3 Gene is Associated with Outcome in Patients with Colorectal Cancer. Hepatogastroenterology. 59(119). 2122–6. 7 indexed citations

18.

Wada, Hiroo, et al.. (2008). A RIGHT HEPATIC ARTERY ANEURYSM INCIDENTALLY FOUND OUT DURING EXPLORATION FOR A SOFT TISSUE TUMOR IN THE RIGHT ELBOW. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 69(8). 2068–2072.

19.

Yoshikawa, Takaki, Kohei Ando, Naoki Ishiwa, et al.. (2005). A Case of Gastric Endocrine Cell Carcinoma with Intramural Metastasis Invading Mainly the Muscle Layer. The Japanese Journal of Gastroenterological Surgery. 38(2). 141–146.

20.

Nomori, Hiroaki, et al.. (1995). Protein 1 (Clara Cell Protein) Serum Levels in Healthy Subjects and Patients With Bacterial Pneumonia. American Journal of Respiratory and Critical Care Medicine. 152(2). 746–750. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact